Forest Laboratories: Clinical Trials

338 trials sponsored by Forest Laboratories, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

278 completed, 42 terminated, 10 unknown, 8 withdrawn. 130 Phase 3, 108 Phase 4, 59 Phase 2, 23 Phase 1, 21 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 3130Completed 108, Terminated 19, Withdrawn 3
Phase 4108Completed 89, Terminated 10, Unknown 5, Withdrawn 4
Phase 259Completed 50, Terminated 8, Withdrawn 1
Phase 123Completed 21, Terminated 1, Unknown 1
Not applicable21Completed 15, Terminated 4, Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow Forest Laboratories: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD
Levomilnacipran, Quetiapine - Major Depressive Disorder
Phase 3CompletedDuke University602017-01-232019-08-14
Antibiotic Prophylaxis in Open Fractures
Ceftaroline - Open Fractures
Phase 4UnknownOlayemi Osiyemi MD502016-12-012016-10-28
Preventing Infections in Orthopaedic Patients
Open Fracture
UnknownOlayemi Osiyemi MD502016-11-012016-10-28
Ceftaroline Diffusion Into Cerebrospinal Fluid of Children
Ceftaroline - Cerebrospinal Fluid Shunts, Ventriculoperitoneal Shunt
Phase 1UnknownBasim Asmar122016-08-012018-10-04
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
Alzheimer Disease
CompletedNYU Langone Health202016-07-012018-01-25
Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage
Diafert - Infertility
CompletedForest Laboratories1002016-06-242017-07-31
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
CAZ-AVI, Vancomycin, Linezolid - Neoplasms, Febrile Neutropenia
Phase 2TerminatedForest Laboratories22016-05-172017-07-21
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
Cariprazine, Placebo - Bipolar Disorder, Depression
Phase 3CompletedForest Laboratories4932016-03-312019-03-12
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
Cariprazine, Placebo - Bipolar Disorder, Depression
Phase 3CompletedForest Laboratories4882016-03-172019-01-30
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Placebo, LIN Dose A, LIN Dose B - Functional Constipation in Children Ages 6-17 Years
Phase 2CompletedForest Laboratories1732015-11-032019-06-19
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Linaclotide - Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation
Phase 4CompletedForest Laboratories8282015-11-012019-08-22
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Linaclotide Dose A, Linaclotide Dose B, Linaclotide Dose C - Irritable Bowel Syndrome With Constipation
Phase 2TerminatedForest Laboratories1012015-11-012020-12-28
Diafert for Embryo Selection and Fertility Improvement (DESTINy)
Daifert, Control Group - Infertility
Phase 3CompletedForest Laboratories1082015-10-262017-08-01
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Linaclotide, Matching Placebo - Irritable Bowel Syndrome With Constipation
Phase 2CompletedIronwood Pharmaceuticals, Inc.7592015-10-222020-04-24
Diafert® for Embryo Selection and Fertility Improvement
Daifert, Control Group - Infertility
Phase 3CompletedForest Laboratories142015-10-222017-08-01
Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
Placebo, Levomilnacipran, Fluoxetine - Major Depressive Disorder
Phase 3CompletedForest Laboratories5522015-06-232020-09-07
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Vilazodone - Major Depressive Disorder
Phase 3CompletedForest Laboratories3302015-05-022019-09-11
Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
Vilazodone, Placebo, Fluoxetine - Major Depressive Disorder
Phase 3CompletedForest Laboratories4732015-02-282019-10-01
The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection
Ceftaroline, Cefazolin / Vancomycin - Surgical Site Infection
Phase 4UnknownUniversity of Cincinnati5002015-01-012015-12-02
Diafert for Embryo Selection and Fertility Improvement
Daifert, Control Group - Infertility
Phase 3CompletedForest Laboratories612014-11-252017-08-01

Showing 20 of 338. Sign in to see all of them.

Conditions studied

Depression (39)  ·  Depressive Disorder, Major (37)  ·  Hypertension (35)  ·  Fibromyalgia (17)  ·  Pain (14)  ·  Alzheimer Disease (13)  ·  Cystic Fibrosis (12)  ·  Exocrine Pancreatic Insufficiency (12)  ·  Schizophrenia (12)  ·  Bipolar Disorder (9)  ·  Diabetes Mellitus, Type 2 (9)  ·  Infections (8)  ·  Anxiety Disorders (7)  ·  Autistic Disorder (7)  ·  Diabetes Mellitus (7)

Interventions

Memantine (41)  ·  Nebivolol (39)  ·  Escitalopram (35)  ·  Milnacipran (28)  ·  Ceftaroline (26)  ·  cariprazine (20)  ·  Metoprolol (18)  ·  Vilazodone Hydrochloride (18)  ·  linaclotide (12)  ·  Sugars (10)  ·  Levomilnacipran (9)  ·  Vancomycin (9)  ·  Acamprosate (8)  ·  dutogliptin (8)  ·  azimilide (7)

Countries

United States (302)  ·  Poland (30)  ·  Ukraine (30)  ·  Canada (27)  ·  Romania (23)  ·  Germany (22)  ·  Spain (22)  ·  Russia (21)  ·  Argentina (19)  ·  Bulgaria (17)  ·  India (17)  ·  France (14)  ·  Hungary (14)  ·  Belgium (12)  ·  Italy (11)

Top investigators

Carl Gommoll, MS (8)  ·  Paul Newell, MBBS, MRCP (5)  ·  David B Bharucha, MD, PhD, FACC (4)  ·  Giovanna Forero, MA (4)  ·  Willie Earley, MD (4)  ·  Allan Spera (3)  ·  Ashwin A Patkar, MD (3)  ·  Elizabeth Diaz, MD (3)  ·  Eric Sicard, M.D. (3)  ·  Jeffrey M. Johnston, MD, FACP (3)  ·  Jordan Lateiner, MS, MBA (3)  ·  Jose M Brum, MD (3)  ·  Kaity Posada, PharmD (3)

Results publications

PMID 33854317, PMID 34091867, PMID 30597021, PMID 34922058, PMID 30221827, PMID 26644957, PMID 29912399, PMID 30061279, PMID 31969269, PMID 32602065, PMID 36006807, PMID 26702925, PMID 27486544, PMID 28692485, PMID 29017067, PMID 29608461, PMID 30380060, PMID 30470662, PMID 30716446, PMID 31344528, PMID 32942346, PMID 33677183, PMID 33915374, PMID 34741280, PMID 37700689, PMID 39520655, PMID 20695801, PMID 21115456, PMID 21438794, PMID 21482570, PMID 21830967, PMID 22106941, PMID 23116208, PMID 23216998, PMID 23357290, PMID 24075889, PMID 24127687, PMID 25312449, PMID 25487791, PMID 26112278, PMID 26845266, PMID 27313268, PMID 27585969, PMID 28478771, PMID 28836957, PMID 31044546, PMID 37551609, PMID 37811711, PMID 39989849, PMID 10109801

NIH funding

2016 (2), 1KL2RR025015-01 (1), 1RL1AG032115-01 (1), 2009 (1), 2014 (1), K23AR057578 (1), P50DA012756 (1), R01MH059380 (1), R01MH059381 (1), R01MH065653 (1), R01MH079414 (1)